The global genomics services market was valued at $8.3 billion in 2023, and is projected to reach $24.0 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033.
► Don’t Miss Out “Download Your Exclusive Sample PDF Report” Now:
https://www.alliedmarketresearch.com/request-sample/A324425
Genomics services encompass sequencing, bioinformatics analysis, sample preparation, library preparation, and annotation services. As precision medicine, biomarker discovery, gene therapy, and personalized healthcare continue to advance, demand for outsourced genomics capabilities has escalated. AI-driven genomic research further accelerates the identification of novel biomarkers and therapeutic targets, fueling expansion.
Key Growth Factors & Barriers
The need for comprehensive genomic data in drug discovery, diagnostics, and clinical research is driving demand. Pharmaceutical and biotech companies increasingly outsource genomics workflows to specialized service providers to reduce cost, complexity, and turnaround time. Moreover, less costly sequencing technologies, advanced bioinformatics platforms, and economies of scale are improving accessibility.
Challenges include data privacy/regulatory concerns, high-quality standards, and the complexity of handling large genomic datasets. Competition is fierce, and maintaining technical differentiation in analytics, turnaround time, and integrative platforms is essential. Also, in certain geographies, infrastructure constraints or regulatory uncertainties may slow adoption.
Segment & Application Highlights
Service types include sequencing (e.g. whole-genome, exome, transcriptome), data analysis, and sample/library prep services. Applications span clinical research, diagnostics, agriculture, microbiome studies, and more. End users include pharmaceutical and biotech companies, academic labs, contract research organizations (CROs), and hospitals.
North America remains the dominant market owing to advanced R&D infrastructure, strong funding, and presence of key service providers. Europe also holds substantial share. Asia-Pacific is the fastest-growing region, driven by expanding biotech R&D, government genomics initiatives in China, India, and Southeast Asia, and rising adoption of personalized medicine.
Competitive Landscape & Strategies
Market participants focus on scale, technological innovation, AI integration, partnerships, acquisitions, and expanding geographic presence. Offering turnkey, end-to-end solutions (from sample to insight) is a common differentiator. Emphasis is placed on workflow automation, data security, regulatory compliance, and scalable cloud-based analytics.
Outlook & Forecast
At an 11.2% CAGR from 2024, the genomics services market is expected to expand from ~$9.2 billion in 2024 to $24 billion by 2033. Growth will be fueled by increasing demand for genomic insights in drug development, diagnostics, agriculture, and precision health, particularly in emerging geographies.
👉 For Purchase Inquiry of Report:
https://www.alliedmarketresearch.com/purchase-enquiry/A324425
In closing, the genomics services market presents a compelling growth story over the next decade. As genomic science becomes more central to healthcare and biotech innovation, stakeholders that position themselves with scalable infrastructure, AI capabilities, and global reach are poised to benefit from the expanding demand for genomic insights and services.
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact Us:
United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
[email protected]
